Predictors of Prognosis in IBD Patients
NCT05653011 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-04-24
Summary
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Conditions
- Inflammatory Bowel Diseases
- Ulcerative Colitis
- Crohn Disease
Interventions
- OTHER
-
Endoscopic biopsy
When patients have colonoscopy or sigmoidoscopy for evaluation of their disease course, biopsied samples are collected. In the IBD group, samples are obtained at endoscopically active and/or inactive lesions. In the control group, samples are obtained at endoscopically normal lesions.
Sponsors & Collaborators
-
Seoul National University Bundang Hospital
lead OTHER
Principal Investigators
-
Nayoung Kim, M.D., Ph.D · Seoul National University Bundang Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-11
- Primary Completion
- 2026-10-31
- Completion
- 2026-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF
NCT01605175 ·Status: COMPLETED
-
Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease
NCT05733845 ·Status: RECRUITING ·Phase: NA
-
Serologic Markers for Inflammatory Bowel Disease During Clinical Forms With Weak or Strong Evolution Capacities
NCT01216514 ·Status: COMPLETED
-
IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE
NCT03809728 ·Status: RECRUITING ·Phase: NA
-
The Comparison Between the Biomarkers in Inflammatory Bowel Disease Patients and General Control Group
NCT03778918 ·Status: UNKNOWN
-
Inflammatory Bowel Disease(IBD), Treatment Response
NCT05350644 ·Status: TERMINATED
-
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
NCT03264690 ·Status: COMPLETED
-
IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study
NCT06573944 ·Status: RECRUITING
-
Intestinal Ultrasound, Magnetic Resonance Enterography, and Conventional Assessment Tools Before and After Treatment of Intestinal Behcet's Disease
NCT06384391 ·Status: RECRUITING
-
Metagenomic Analysis of Gut Microbiome in Korean Patients With Ulcerative Colitis
NCT01010815 ·Status: UNKNOWN
-
Changing the Future of Intestinal Failure in Intestinal Chronic Inflammation (INT-FAIL)
NCT06777251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Microbiome and Genetic Analysis of Familial IBD
NCT03515070 ·Status: COMPLETED
-
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
NCT07172945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multi-omics to Predict Responses to Biologics in IBD
NCT05542459 ·Status: UNKNOWN
-
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
NCT06591013 ·Status: COMPLETED ·Phase: NA
-
Long-term Follow-up of Anal Fistulae in Crohn's Disease Treated With Anti-TNFalpha and Interest of New MRI Sequences
NCT02883296 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Intestinal Microbiota in Patients With Inflammatory Bowel Disease and/or Spondyloarthritis and Study of the Impact of an Anti-TNF Alpha Therapy
NCT03359642 ·Status: COMPLETED ·Phase: NA
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
NCT05230173 ·Status: RECRUITING ·Phase: NA
-
A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD
NCT04079335 ·Status: UNKNOWN
-
Specific microRNAs as Potential Biomarker for Inflammatory Bowel Disease
NCT03698500 ·Status: UNKNOWN ·Phase: NA
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN
-
Clinical Study on the Distribution of Digestive Tract Microbiota Before and After Ileocecal Resection in Crohn's Disease
NCT05615116 ·Status: UNKNOWN
-
Biomarkers in Inflammatory Bowel Diseases
NCT02612103 ·Status: COMPLETED
-
Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease
NCT06299631 ·Status: COMPLETED
-
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
NCT01183403 ·Status: COMPLETED